Ensysce Biosciences, Inc. (NASDAQ: ENSC) has completed the acquisition of privately held Cy Biopharma, Inc., a clinical-stage biotechnology company developing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE